Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer.

Avril, Norbert; Sassen, Stefanie; Schmalfeldt, Barbara; Naehrig, Joerg; Rutke, Stephan; Weber, Wolfgang A; Werner, Martin; Graeff, Henner; Schwaiger, Markus; Kuhn, Walther

Avril, Norbert; Sassen, Stefanie; Schmalfeldt, Barbara; Naehrig, Joerg; Rutke, Stephan; Weber, Wolfgang A; Werner, Martin; Graeff, Henner; Schwaiger, Markus; Kuhn, Walther.

Affiliation

Avril N; University of Pittsburgh Medical Center, Division of Nuclear Medicine, 200 Lothrop St, Pittsburgh, PA, 15213, USA. n.e.avril@qmul.ac.uk

J Clin Oncol ; 23(30): 7445-53, 2005 Oct 20.

Article in En | MEDLINE | ID: mdl-16157939

Subject(s)

Fluorodeoxyglucose F18; Neoadjuvant Therapy; Ovarian Neoplasms/diagnostic imaging; Ovarian Neoplasms/drug therapy; Radiopharmaceuticals; Adult; Female; Humans; Positron-Emission Tomography/methods; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Survival Rate

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Radiopharmaceuticals / Fluorodeoxyglucose F18 / Neoadjuvant Therapy Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: J Clin Oncol Year: 2005 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links